AgingResearch.NewsJoin free

Coenzyme Q10 + selenium

Intervention

1 paper1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Human trial1

Outcomes

1

proBNPage

no changein humans1

1 study

  1. Coenzyme Q10 + selenium has no effect on proBNPage in humans.

    “Partly because of dropouts and inadequate treatment intake, groups A and C showed non-significant differences in the primary and secondary variables.”

    Human trialGroup A versus placebo; dropouts and inadequate treatment intakecoenzyme Q10 100 mg bid + selenium 100 mcg2 years

    The proBNPage reduction (PBAR) trial-results of a randomized, double blind, placebo-controlled, pilot study to fine tune an NT-proBNP-based method to assess the effect of anti-aging treatments

    GeroScience8 Sep 2025

More on proBNPage

Latest

Related